BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 29730075)

  • 1. Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options.
    Mota FC; Cecconello I; Takeda FR; Tustumi F; Sallum RAA; Bernardo WM
    Int J Surg; 2018 Jun; 54(Pt A):176-181. PubMed ID: 29730075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness of upfront esophagectomy versus induction chemoradiation in clinical stage T2N0 esophageal cancer: A decision analysis.
    Semenkovich TR; Panni RZ; Hudson JL; Thomas T; Elmore LC; Chang SH; Meyers BF; Kozower BD; Puri V
    J Thorac Cardiovasc Surg; 2018 May; 155(5):2221-2230.e1. PubMed ID: 29428700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant Therapy Vs Upfront Surgery for Clinical T2N0 Esophageal Cancer: A Systematic Review.
    Kidane B; Korst RJ; Weksler B; Farrell A; Darling GE; Martin LW; Reddy R; Sarkaria IS
    Ann Thorac Surg; 2019 Sep; 108(3):935-944. PubMed ID: 31077657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing the interval between neoadjuvant chemoradiotherapy and surgery in esophageal cancer: a meta-analysis of published studies.
    Lin G; Han SY; Xu YP; Mao WM
    Dis Esophagus; 2016 Nov; 29(8):1107-1114. PubMed ID: 26542065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thoracic versus cervical anastomosis on anastomotic leak among patients who undergo esophagectomy after neoadjuvant chemoradiation.
    Chidi AP; Etchill EW; Ha JS; Bush EL; Yang SC; Battafarano RJ; Broderick SR
    J Thorac Cardiovasc Surg; 2020 Oct; 160(4):1088-1095. PubMed ID: 32299695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer.
    Urschel JD; Vasan H; Blewett CJ
    Am J Surg; 2002 Mar; 183(3):274-9. PubMed ID: 11943125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes following neoadjuvant chemoradiotherapy in patients with clinical T2N0 esophageal squamous cell carcinoma.
    Chen WH; Chao YK; Chang HK; Tseng CK; Wu YC; Liu YH; Hsieh MJ; Liu HP
    Dis Esophagus; 2012 Apr; 25(3):250-5. PubMed ID: 21951719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study.
    Markar SR; Gronnier C; Pasquer A; Duhamel A; Beal H; Théreaux J; Gagnière J; Lebreton G; Brigand C; Meunier B; Collet D; Mariette C;
    Eur J Cancer; 2016 Mar; 56():59-68. PubMed ID: 26808298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of upfront surgery for patients with unsuspected lymph node metastasis in esophageal cancer: a propensity scoring matching study.
    Park JK; Kim JJ; Moon SW; Cho DG
    J Cardiothorac Surg; 2018 Jun; 13(1):62. PubMed ID: 29880029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upfront surgery and pathological stage-based adjuvant chemoradiation strategy in locally advanced esophageal squamous cell carcinoma.
    Chen HS; Hsu PK; Liu CC; Wu SC
    Sci Rep; 2018 Feb; 8(1):2180. PubMed ID: 29391589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 15-Year Experience with Multimodality Therapy Including Esophagectomy for Elderly Patients with Locoregional Esophageal Cancer.
    Sawyer WP; Luo X; Welch AM; Bolton NM; Brown R; Bolton JS
    J Am Coll Surg; 2021 Apr; 232(4):580-588. PubMed ID: 33549634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
    Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
    Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and Radiation.
    Spector R; Zheng Y; Yeap BY; Wee JO; Lebenthal A; Swanson SJ; Marchosky DE; Enzinger PC; Mamon HJ; Lerut A; Odze R; Srivastava A; Agoston AT; Tippayawang M; Bueno R;
    Semin Thorac Cardiovasc Surg; 2015; 27(2):205-15. PubMed ID: 26686448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged interval between neoadjuvant chemoradiotherapy and esophagectomy does not benefit the outcome in esophageal cancer: a systematic review and meta-analysis.
    Tie H; He F; Shen J; Zhang B; Ye M; Chen B; Wu Q
    Dis Esophagus; 2018 Jan; 31(1):1-9. PubMed ID: 29087451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does timing of esophagectomy following neoadjuvant chemoradiation affect outcomes? A meta-analysis.
    Qin Q; Xu H; Liu J; Zhang C; Xu L; Di X; Zhang X; Sun X
    Int J Surg; 2018 Nov; 59():11-18. PubMed ID: 30261331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of robotic-assisted transhiatal esophagectomy for esophageal cancer after neoadjuvant chemoradiation.
    Coker AM; Barajas-Gamboa JS; Cheverie J; Jacobsen GR; Sandler BJ; Talamini MA; Bouvet M; Horgan S
    J Laparoendosc Adv Surg Tech A; 2014 Feb; 24(2):89-94. PubMed ID: 24401141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival Benefit of Neoadjuvant Treatment in Clinical T3N0M0 Esophageal Cancer: Results From a Retrospective Multicenter European Study.
    Mantziari S; Gronnier C; Renaud F; Duhamel A; Théreaux J; Brigand C; Carrère N; Lefevre JH; Pasquer A; Demartines N; Collet D; Meunier B; Mariette C;
    Ann Surg; 2017 Nov; 266(5):805-813. PubMed ID: 28742698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
    Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Efficacy of Neoadjuvant Versus Adjuvant Therapy for Resectable Esophageal Cancer Patients: A Systematic Review and Meta-Analysis.
    Xiao X; Hong HG; Zeng X; Yang YS; Luan SY; Li Y; Chen LQ; Yuan Y
    World J Surg; 2020 Dec; 44(12):4161-4174. PubMed ID: 32761259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.